Welcome to CNDR
The Center for Neurodegenerative Disease Research (CNDR) promotes and conducts multidisciplinary clinical and basic research studies aimed at increasing our understanding of the causes and mechanisms leading to brain dysfunction and degeneration in Alzheimer's disease (AD), Parkinson's disease (PD), Frontotemporal disease (FTD), amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), and other neurodegenerative disorders that occur more frequently with advancing age. |
What's New?
- Philadelphia philanthropists
John O. Haas and Dr. Janet Haas
to support pilot studies in Alzheimer’s disease drug discovery. More information...
- New Video Resource on Alzheimer's Disease and Healthy Brain Aging: "Progress and Promise Against Alzheimers Disease." More Information and Additional Video Resources on Alzheimer's...
"Can Alzheimer's Disease Be Prevented?," a newly updated booklet from the National Institute on Aging (NIA), answers questions about brain health and summarizes the latest research about AD prevention. More information...- Click here for more on The Alzheimer's Project, a multi-platform public health series that seeks to bring a wider public understanding of Alzheimer's disease research and care. Co-presented by HBO and NIA.
- The Latest Research and News From the Lab: Feature on WHYY’s Radio Times discussing Alzheimer’s disease. More information...
Penn Medicine Pathologists Pioneer Biomarker Test to Diagnose or Rule Out Alzheimer’s Disease. More information on this and other recent findings in the lab... - 2010 Alzheimer's Disease Center Pilot Research Grants Announced. More information...
- Alzheimer's Association released its 2009 Alzheimer's Facts and Figures Report and the Alzheimer's Study Group has released its National Alzheimer's Strategic Plan today as part of a hearing on the group’s work before the Senate Special Committee on Aging.